800+
Attendees
500+
Companies
250+
Speakers
80+
Exhibitors
8
Tracks
6
Workshops

Bioprocessing Tracks

 

Cell Therapy Manufacture

• Continuous manufacture

• Process development: Scale up and scale out

• GMP Manufacturing & formulation of finished product

• Preserving cell quality

• Expansion

• Supply Chain Management

• Cryopreservation & labelling

• Cell banking & repositories

• Logistics, Transport & Shipping

• Facility design

• Successful tech transfer

• Keeping a clean room

• De-risking supply chain

Gene Therapy Manufacture

• Safety, efficacy and efficiency

• Reducing cost

• Gene Editing & CRISPR

• Closed systems for CAR T cell production

• Manufacture development

• Process development: Scale up and scale out

• GMP Manufacturing & formulation of finished product

• Non-clinical development programmes

 

2019 Speakers

 

  • Dr Roy Baynes at World Advanced Therapies & Regenerative Medicine Congress 2019
    Dr Roy Baynes
    Senior Vice President And Head Global Clinical Development, Chief Medical Officer
    Merck Sharp and Dohme (MSD)
    Katherine High, M.D. at World Advanced Therapies & Regenerative Medicine Congress 2019
    Katherine High, M.D.
    President And Head, Research And Development
    Spark Therapeutics
    Dr Andre Choulika at World Advanced Therapies & Regenerative Medicine Congress 2019
    Dr Andre Choulika
    Chairman And Chief Executive Officer
    Cellectis
  • Andrew Obenshain at World Advanced Therapies & Regenerative Medicine Congress 2019
    Andrew Obenshain
    Head Of Europe
    Bluebird Bio
    Alan Smith at World Advanced Therapies & Regenerative Medicine Congress 2019
    Alan Smith
    Executive Vice President, Technical Operations
    Bellicum Pharmaceuticals
    Bob Smith at World Advanced Therapies & Regenerative Medicine Congress 2019
    Bob Smith
    Senior Vice President, Global Gene Therapy Business
    Pfizer
  • Shinya Yamanaka at World Advanced Therapies & Regenerative Medicine Congress 2019
    Shinya Yamanaka
    Director And Professor, Center For Ips Cell Research And Application (Cira)
    Kyoto University
    Dr Joanne Kurtzberg at World Advanced Therapies & Regenerative Medicine Congress 2019
    Dr Joanne Kurtzberg
    Director
    Carolinas Cord Blood Bank At Duke
    Dr James Miskin at World Advanced Therapies & Regenerative Medicine Congress 2019
    Dr James Miskin
    Chief Technical Officer
    Oxford BioMedica
  • Frederic Chereau at World Advanced Therapies & Regenerative Medicine Congress 2019
    Frederic Chereau
    Chief Executive Officer
    LogicBio Therapeutics
    Lothar Germeroth at World Advanced Therapies & Regenerative Medicine Congress 2019
    Lothar Germeroth
    Senior Vice President And Managing Director
    Juno Therapeutics GmbH, A Celgene Company
    Derek Jantz at World Advanced Therapies & Regenerative Medicine Congress 2019
    Derek Jantz
    Co-Founder And Cso
    Precision Biosciences
  • Michael Leek at World Advanced Therapies & Regenerative Medicine Congress 2019
    Michael Leek
    Chief Executive Officer
    TC BioPharm
    Lior Raviv at World Advanced Therapies & Regenerative Medicine Congress 2019
    Lior Raviv
    Vice President Of Development
    Pluristem
    Edward Rebar at World Advanced Therapies & Regenerative Medicine Congress 2019
    Edward Rebar
    Senior Vice President And Chief Technology Officer
    Sangamo Therapeutics
  • Antonio Regalado at World Advanced Therapies & Regenerative Medicine Congress 2019
    Antonio Regalado
    Senior Editor
    M.I.T. Technology Review
    Dominic Schmidt at World Advanced Therapies & Regenerative Medicine Congress 2019
    Dominic Schmidt
    Partner
    Syncona Investment Management Ltd
    R Session Ii at World Advanced Therapies & Regenerative Medicine Congress 2019
    R Session Ii
    ‎Senior Vice President of Corporate Strategy & Project Management
    4DMT
  • Fraser Wright at World Advanced Therapies & Regenerative Medicine Congress 2019
    Fraser Wright
    CTO
    Axovant Sciences
    Dr Robert Deans at World Advanced Therapies & Regenerative Medicine Congress 2019
    Dr Robert Deans
    Chief Technology Officer
    Blue Rock Therapeutics
    Jean-Pierre Latere at World Advanced Therapies & Regenerative Medicine Congress 2019
    Jean-Pierre Latere
    Chief Operating Officer
    Celyad
  • Neill Moray Mackenzie at World Advanced Therapies & Regenerative Medicine Congress 2019
    Neill Moray Mackenzie
    Chairman And Board Mamber
    Cellular Therapeutics Ltd
    Dr Frédéric Triebel at World Advanced Therapies & Regenerative Medicine Congress 2019
    Dr Frédéric Triebel
    Chief Scientific Officer And Medical Officer
    Prima Biomed, Ltd
    Dr Michael West at World Advanced Therapies & Regenerative Medicine Congress 2019
    Dr Michael West
    Chief Executive Officer
    AgeX Therapeutics
  • Jacqueline Barry at World Advanced Therapies & Regenerative Medicine Congress 2019
    Jacqueline Barry
    Chief Clinical Officer
    Cell and Gene Therapy Catapult
    Jaap Boelens at World Advanced Therapies & Regenerative Medicine Congress 2019
    Jaap Boelens
    Chief; Stem Cell Transplantation And Cellular Therapies Pediatrics
    Memorial Sloan-Kettering Cancer Center
    Armando Cuesta Díaz at World Advanced Therapies & Regenerative Medicine Congress 2019
    Armando Cuesta Díaz
    Partner
    Ilana Capital
  • Daniel Gibson at World Advanced Therapies & Regenerative Medicine Congress 2019
    Daniel Gibson
    Head Of Innovation And Commercialation
    Anthony Nolan
    Adam Gridley at World Advanced Therapies & Regenerative Medicine Congress 2019
    Adam Gridley
    President And Chief Executive Officer
    Histogenics Corporation
    Michael Hunt at World Advanced Therapies & Regenerative Medicine Congress 2019
    Michael Hunt
    Chief Executive Officer
    ReNeuron Group Plc
  • Dmitry Kuzmin at World Advanced Therapies & Regenerative Medicine Congress 2019
    Dmitry Kuzmin
    Managing Partner
    4Bio Capital
    Alan Muir at World Advanced Therapies & Regenerative Medicine Congress 2019
    Alan Muir
    Director And Co-Founder
    Seven Hills Venture Partners
    David Pauza at World Advanced Therapies & Regenerative Medicine Congress 2019
    David Pauza
    Chief Science Officer
    American Gene Technologies International Inc.
  • Beth Shaz at World Advanced Therapies & Regenerative Medicine Congress 2019
    Beth Shaz
    Chief Medical Officer
    New York Blood Center
    Jonathan Sheffield at World Advanced Therapies & Regenerative Medicine Congress 2019
    Jonathan Sheffield
    Chief Executive Officer
    NIHR Clinical Research Network
    Dr Andrea Spezzi at World Advanced Therapies & Regenerative Medicine Congress 2019
    Dr Andrea Spezzi
    Chief Medical Officer and Co-founder
    Orchard Therapeutics
  • Michael Stein at World Advanced Therapies & Regenerative Medicine Congress 2019
    Michael Stein
    Chief Executive Officer
    Oxstem
    Marcos Valadares at World Advanced Therapies & Regenerative Medicine Congress 2019
    Marcos Valadares
    Co-Founder
    Pluricell
    Rogerio Vivaldi at World Advanced Therapies & Regenerative Medicine Congress 2019
    Rogerio Vivaldi
    Chief Executive Officer
    Sigilon Therapeutics
  • Mark Lowdell at World Advanced Therapies & Regenerative Medicine Congress 2019
    Mark Lowdell
    Director Of Cellular Therapy
    Royal Free London NHS Foundation Trust
    Miguel Forte at World Advanced Therapies & Regenerative Medicine Congress 2019
    Miguel Forte
    Chief Executive Officer
    Zelluna Immunotherapy
    Edward Hodgkin at World Advanced Therapies & Regenerative Medicine Congress 2019
    Edward Hodgkin
    Partner
    Syncona Partners
  • Hans Keirstead at World Advanced Therapies & Regenerative Medicine Congress 2019
    Hans Keirstead
    Chief Executive Officer
    AiVita Biomedical
    Douglas Losordo at World Advanced Therapies & Regenerative Medicine Congress 2019
    Douglas Losordo
    Chief Medical Officer
    Caladrius
    David Mazzo at World Advanced Therapies & Regenerative Medicine Congress 2019
    David Mazzo
    Chief Executive Officer
    Caladrius Biosciences
  • David Morrow at World Advanced Therapies & Regenerative Medicine Congress 2019
    David Morrow
    Project Manager
    EATRIS
    Mike Rice at World Advanced Therapies & Regenerative Medicine Congress 2019
    Mike Rice
    Principal
    Defined Health
    Mark Sawicki at World Advanced Therapies & Regenerative Medicine Congress 2019
    Mark Sawicki
    Chief Commercial Officer
    Cryoport Inc
  • Elizabeth Shpall at World Advanced Therapies & Regenerative Medicine Congress 2019
    Elizabeth Shpall
    Director
    MD Anderson Cancer Center
    Claudia Mitchell at World Advanced Therapies & Regenerative Medicine Congress 2019
    Claudia Mitchell
    Chief Operations Officer
    Universal Cells
    Sean Ainsworth at World Advanced Therapies & Regenerative Medicine Congress 2019
    Sean Ainsworth
    Chief Executive Officer And Chairman
    Immusoft Corporation
  • Stephan Grupp at World Advanced Therapies & Regenerative Medicine Congress 2019
    Stephan Grupp
    Chief, Cellular Therapy and Transplant Section
    The Children's Hospital of Philadelphia
    Sam Hall at World Advanced Therapies & Regenerative Medicine Congress 2019
    Sam Hall
    Principal
    Apple Tree Partners
    Takashi Kei Kishimoto at World Advanced Therapies & Regenerative Medicine Congress 2019
    Takashi Kei Kishimoto
    Chief Science Officer
    Selecta Biosciences Inc
  • Xiaokui Zhang at World Advanced Therapies & Regenerative Medicine Congress 2019
    Xiaokui Zhang
    Chief Scientific Officer
    Celularity
    Ross Macdonald at World Advanced Therapies & Regenerative Medicine Congress 2019
    Ross Macdonald
    Chief Executive Officer
    Cynata Therapeutics Ltd
    Thomas Hach at World Advanced Therapies & Regenerative Medicine Congress 2019
    Thomas Hach
    Global Brand Medical Director Neuroscience
    Novartis
  • Stefanos Theoharis at World Advanced Therapies & Regenerative Medicine Congress 2019
    Stefanos Theoharis
    Senior Vice President Of Corporate Development And Partnering
    Cell Medica Ltd
    Susan Solomon at World Advanced Therapies & Regenerative Medicine Congress 2019
    Susan Solomon
    CEO and Founder
    The New York Stem Cell Foundation Research Institute

 

 

SEE ALL SPEAKERS

Sign Up for Event Updates

 

Companies that attend include

 

 

Advanced Therapies

 

 

 

Cord Blood

 

 

 

 

 

 

Sponsorship packages are tailored to meet your specific business development goals
 

DOWNLOAD PROSPECTUS

TO SPONSOR / EXHIBIT

Erica Baeta
+44 (0)207 092 1152
erica.baeta@terrapinn.com

TO SPEAK

Jessica Robinson
t/ +44 (0)207 092 1150
jessica.robinson@terrapinn.com

TO REGISTER

Issa Mauthoor
+44 (0)207 092 1257
issa.mauthoor@terrapinn.com

See you in London  |  15th - 17th May 2019

 

 

REGISTER NOW

There are two parts to the World Advanced Therapies & Regenerative Medicine Congress: a conference and an exhibition featuring solutions for pharma and biotech.

There is a registration fee to attend the conferences. To visit the exhibition is free.

TO SPONSOR / EXHIBIT

Erica Baeta 
+44 (0)207 092 1152 
erica.baeta@terrapinn.com

TO SPEAK

Jessica Robinson 
t/ +44 (0)207 092 1150 
jessica.robinson@terrapinn.com

TO REGISTER

Issa Mauthoor 
+44 (0)207 092 1257 
issa.mauthoor@terrapinn.com